Clinical Trial Update: Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye [Phase 2]

View source ↗

Summary

Results from a late Phase II confirmatory trial of DE-089 ophthalmic solution for dry eye disease have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• DE-089 Ophthalmic Solution

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2014-08-08